BioSpace News Archive

ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, announced the appointment of Ken Lock as Chief Commercial Officer, effectively immediately.

Samsung Biologics, a global contract development and manufacturing organization, released its 2023 Environmental, Social and Governance Report.

Resonetics have announced a strategic partnership to provide integrated power solutions for the implantable medical device industry.

Exscientia plc (Nasdaq: EXAI) today announced the initiation of EXCYTE-1, a prospective observational study in ovarian cancer to investigate the relationship between ex vivo drug response (EVDR) in primary tumour-derived samples using the company’s precision medicine platform and actual patient clinical response.

Varex Schedules Third Quarter Fiscal Year 2023 Earnings Release and Conference Call.

PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has announced it has added Dr. Jeffrey P. Carpenter, Jeffrey O’Donnell, Sr. and Samuel E. Navarro to its board of directors.

Bicycle Therapeutics plc today announced the closing on Monday, July 17, 2023 of its underwritten public offering of 6,117,648 American Depositary Shares (“ADSs”), each representing one ordinary share.

City of Hope, one of the largest cancer research and treatment organizations in the United States and a National Cancer Institute-designated comprehensive cancer Center, and Calidi Biotherapeutics Inc. today jointly announced that the first brain tumor patient was treated at City of Hope.

NeoGenomics, Inc.today announced that it will report its second quarter 2023 financial results on Tuesday, August 8, 2023.

BridgeBio Pharma, Inc. today announced that on July 10, 2023, the compensation committee of BridgeBio’s board of directors granted eight new employees restricted stock units for an aggregate of 71,250 shares of the Company’s common stock.